GlioCART Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $62.5K

  • Investors
  • 3

GlioCART General Information

Description

Developer of cell-based immunotherapy technology designed for the treatment of aggressive brain cancers. The company's platform offers to engineer genetically modified immune cells to selectively target and destroy tumor cells while simultaneously reprogramming the immunosuppressive microenvironment, enabling oncology researchers and clinicians to address key resistance mechanisms in glioblastoma, improve patient survival, and offer a more effective and durable therapeutic option for individuals with limited treatment alternatives.

Contact Information

Website
www.gliocart.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kreuzstrasse 4
  • 4123 Allschwil
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Kreuzstrasse 4
  • 4123 Allschwil
  • Switzerland

GlioCART Timeline

2026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlioCART Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 17-Nov-2025 $62.5K Completed Pre-Clinical Trials
3. Seed Round 05-Nov-2025 Completed Pre-Clinical Trials
2. Grant 18-Mar-2025 $112K Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2025 Completed Pre-Clinical Trials
To view GlioCART’s complete valuation and funding history, request access »

GlioCART Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlioCART Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Office (Accelerator/Incubator) Accelerator/Incubator
Venture Kick Accelerator/Incubator
University of Basel University Minority
To view GlioCART’s complete investors history, request access »

Ready to get started?

Request a free trial

GlioCART FAQs

  • When was GlioCART founded?

    GlioCART was founded in 2025.

  • Where is GlioCART headquartered?

    GlioCART is headquartered in Allschwil, Switzerland.

  • What is the size of GlioCART?

    GlioCART has 5 total employees.

  • What industry is GlioCART in?

    GlioCART’s primary industry is Drug Discovery.

  • Is GlioCART a private or public company?

    GlioCART is a Private company.

  • What is GlioCART’s current revenue?

    The current revenue for GlioCART is .

  • How much funding has GlioCART raised over time?

    GlioCART has raised $238K.

  • Who are GlioCART’s investors?

    Innovation Office (Accelerator/Incubator), Venture Kick, and University of Basel have invested in GlioCART.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process